Press release
Ocular Inflammation Treatment Market is Pegged to Expand at a CAGR of 6.9% in Terms of Value from 2017-2026
Increasing contamination of environment by emission of toxins has elevated the risks of ocular inflammation, also known as uveitis. Evolving medical technologies and drug discovery developments have paved way for effective treatment of ocular inflammation. A range of options for treatment of ocular inflammation are being offered to patients – mild inflammations are being treated by the use of corticosteroid eye drops, while oral administration of immunosuppressive agents is being preferred to treat posterior uveitis in both eyes.
Read Report Overview @ https://www.transparencymarketresearch.com/ocular-inflammation-treatment-market.html
As global pollution levels soar uncontrollably, future generations will be more susceptible to eye inflammations, putting stress on healthcare industry participants in creating affordable and accessible avenues for adopting ocular inflammation treatments. Transparency Market Research foresees that by the end of 2026, over US$ 1 billion worth of revenues will be generated by the sales of drugs and adoption of medical procedures for ocular inflammation treatment.
Currently, the incidence of such sight-impairing disorders is witnessing a sharp increase instrumented by multiple causes, from autoimmunity problems and bruising the eyes to infections occurring near the eye. Toxins penetrating the eyes are observed as the foremost factor driving the global incidence rate of uveitis in the coming years. During the period, 2017-2026, the global market for ocular inflammation treatment will be reflecting a high value growth at a CAGR of 6.9%.
By 2026-end, over US$ 300 million worth of corticosteroids will be used for ocular inflammation treatment
In 2018 and beyond, majority of uveitis patients will be using corticosteroid eye drops for treating their eye inflammations. Considering how ocular inflammation at the back of eyes can become extremely severe if unattended, corticosteroid eye drops are being viewed as the most affordable, convenient and effective treatment for such ocular inflammations.
Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41027
50% of ocular inflammation treatments will be directed towards anterior uveitis
Anterior uveitis is characterized by its localization – front of the eye, making it the most common form of ocular inflammation in the world. Young and middle-aged demographics are most susceptible to anterior ocular inflammation. Severity of anterior uveitis can also lead to lung infections, gastrointestinal problems and rheumatologic diseases. By 2026-end, more than US$ 530 million worth of ocular inflammation treatments will be used to cure anterior uveitis.
High Uptake Combination Therapies to Drive Discovery of New Drugs on Ocular Inflammation Treatment
For long-term effectiveness, majority of ocular inflammation patients are preferring combination therapy, wherein therapeutic procedures are supported by a prescribed intake of medicines and pharmaceutical drugs. In mid-2017, the FDA’s uveitis pipeline has witnessed the emergence of new drugs & therapies, which include ADX-2 or NS2 by Aldeyra Therapeutics, a dexamethasone implant developed called Ozurdex developed by Allergan, and fluocinolone inserts such as Medidur by pSivida.
In the coming years, majority of products and therapies on ocular inflammation treatments will be developed by companies namely, Allergan Plc., Valeant Pharmaceuticals International, Inc., Novartis AG, Abbvie, Inc., Eyegate Pharmaceuticals, Inc., Alimera Sciences, Inc., pSivida Corporation, Cipla Ltd., Pfizer, Inc., and Akorn, Inc. Novel injection techniques will be introduced for treating ocular inflammations with new formulations. Through 2026, several market players will also focus on discovering new local steroidal agents to treat non-infectious ocular inflammations.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41027
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ocular Inflammation Treatment Market is Pegged to Expand at a CAGR of 6.9% in Terms of Value from 2017-2026 here
News-ID: 1405687 • Views: …
More Releases from Transparency Market Research
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the…
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359
Key Players and Market Developments
Key players…
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period.
Moreover, the market is expected…
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market.
Vascular closure devices is estimated to reach a value of ~US$ 1 Bn…
More Releases for Ocular
Developments in Gene Therapy for Ocular Diseases
The Ophthalmic drugs industry continues to expand year on year, with an ageing population there is continual demand for advancements in ophthalmic treatments. This year's Ophthalmic Drugs Conference will have a key focus on gene therapy and artificial intelligence with developments on the latest drug pipelines and clinical trials.
The conference will convene on 21 - 22 November 2022 in London, UK, this year attendees will hear from industry giants about…
Advancement In Ocular Surgery And New Launches Of Ocular Devices Are Expected To …
The Global Ocular Surgery Market, by device type (Cataract surgery devices, Glaucoma surgery devices, and Vitrectomy surgery devices) and region was valued at US$ 1,517.5 million in 2017 and is projected to exhibit a CAGR of 7.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing aging population and high incidence rate of diabetes coupled with technological advancement are drivers fueling growth…
Global Ocular Drug Delivery Technology Market 2017 – 2025 : Attractiveness, An …
Researchmoz added Most up-to-date research on "Ocular Drug Delivery Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports.
Ocular Drug Delivery Technology Market: Overview
This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel drug delivery technologies, increase in…
Ocular Hypertension - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape.
Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor…
Ocular Drug Delivery Technology Market grows with increasing preference among pa …
Global Ocular Drug Delivery Technology Market: Overview
The top three players in the global ocular drug delivery technology market hold more than 50.0% share in it. This makes the competitive landscape consolidated. The topnotch players have climbed to the top owing to their broad range of topical ocular drug products.
A noticeable trend in the global ocular drug delivery technology market is the small and large regional players collaborating with…
Ocular Hypertension-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Ocular Hypertension-Pipeline Review H2 2017” this report provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape.
Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up, causing ocular hypertension. There are no symptoms with ocular hypertension. Risk factors include…
